Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer

Παρόμοια τεκμήρια

• Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
  ανά: Gradishar, William J
  Έκδοση: (2016)
• Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers
  ανά: Migliaccio, Ilenia, κ.ά.
  Έκδοση: (2015)
• Advances in endocrine and targeted therapy for hormone-receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
  ανά: Shen, Le-Sang, κ.ά.
  Έκδοση: (2020)
• Endocrine therapies in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative, pretreated, advanced breast cancer: A network meta-analysis
  ανά: Lee, Cho-Hao, κ.ά.
  Έκδοση: (2020)
• Patients’ preferences for postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treatments in Japan
  ανά: Omori, Yukie, κ.ά.
  Έκδοση: (2019)